The Food and Drug Administration (FDA) is looking to AI to solve the problem of lengthy approval processes, as the Trump ...

The U.S. Food and Drug Administration (FDA) says it plans to use artificial intelligence (AI) to help speed the approval of ...

Capricor expressed confidence that the facility will meet the necessary requirements to support product licensure and ...

We recently wrote an introductory overview of navigating the Common Law Research Exemption and the Hatch-Waxman Safe Harbor ...

The American Board of Cosmetic Surgery (ABCS) announced that a new wrinkle-reducing, Botox-type injectable, Letybo ...

U.S. FDA successfully completed Pre-License Inspection; Company expects facility will meet all requirements to support ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

The state is devoting $50 million to a research consortium looking into the effects of ibogaine, an illegal drug being touted ...

PDUFA date of June 13th 2025 by which FDA will decide upon whether or not UGN-102 should be approved for patients with ...

With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...

OneSource Specialty Pharma partners with Xbrane Biopharma for biosimilar manufacturing, aiming to strengthen global supply ...

Insmed achieved positive phase 2b results for TPIP in PAH. Click here to find out why INSM stock is a Strong Buy.